Sulfatase inhibiting progestogen-only contraceptive regimens
OwnerPatrick Michel Caubel, Andrew Joseph Friedmaninventors
Life of this patent
Estimating the term…
Abstract
A method of contraception is disclosed comprising the step of administering to a menstruating female a cycle of contraceptive therapy, said cycle of therapy including the continuous administration for the length of the cycle of a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of the administration of an estrogen.
Claims4
A method of contraception comprising the step of administering to a menstruating female a cycle of contraceptive therapy, said cycle of therapy including the continuous administration for the length of the cycle of a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of the administration of an estrogen.
A contraceptive therapy unit for administration to a menstruationg female comprising a cycle of separate dosage units adapted for successive daily oral administration for the length of the cycle, wherein said dosage units contain, in admixture with a pharmaceutically acceptable carrier, a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of an estrogen.
A contraceptive therapy unit for administration to a menstruationg female comprising a cycle of transdermal patches adapted for successive administration for the length of the cycle, wherein said transdermal patches contain, in a suitable matrix, a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of an estrogen.
A contraceptive therapy unit for administration to a menstruationg female comprising a cycle of vaginal rings adapted for successive administration for the length of the cycle, wherein the vaginal rings contain, in a suitable matrix, a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of an estrogen.
Dependencies are inferred from the claim text.